doi: 10.1126/scitranslmed.adj9332 99 GinhouxF.GreterM.LeboeufM.NandiS.SeeP.GokhanS.et al
Follistatin Gene Therapy Research in Humans Phase 1/2a clinical trial data for AAV1-FS344 in Becker muscular dystrophy patients demonstrated a statistically significant average 11.5% improvement in six-minute walk test performance at 6 months (p = 0.02), with the degree of pre-existing muscle fibrosis at baseline identified as the strongest predictor of treatment response
No peptide does the work for you
Intriguingly, the fast and transient increase of [Ca 2+ ] cyt was notably triggered in systemic leaves (including leaf 3, 4, and 6) by GSH (Supplementary Movie 3) at the level comparable to that induced by Glu (Fig
When the LMP is not repaired, persistent lysosomal rupture may lead to the massive release of lysosomal contents, cascade hydrolysis of cytoplasmic contents, and extensive cytoplasmic acidification, thus contributing to irreversible cell damage 76
Evaluation of bacterial and fungal biomarkers for differentiation and prognosis of patients with inflammatory bowel disease
